Bicara Therapeutics BCAX Accumulated Depreciation Depletion And Amortization Sale Of Property Plant And Equipment1
Accumulated Depreciation Depletion And Amortization Sale Of Property Plant And Equipment1 at other companies
Other financials
Where this comes from
Reported directly by Bicara Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:AccumulatedDepreciationDepletionAndAmortizationSaleOfPropertyPlantAndEquipment1.
The official record: Bicara Therapeutics’s 10-K, filed March 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bicara Therapeutics's accumulated depreciation depletion and amortization sale of property plant and equipment1.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Bicara Therapeutics's accumulated depreciation depletion and amortization sale of property plant and equipment1?
- Bicara Therapeutics (BCAX) reported accumulated depreciation depletion and amortization sale of property plant and equipment1 of $0 in Q4 2025.
- What does accumulated depreciation depletion and amortization sale of property plant and equipment1 mean?
- This metric represents the cumulative amount of depreciation, depletion, and amortization recorded against property, plant, and equipment assets since their acquisition. It reflects the total historical cost allocated to expense over the useful lives of these assets. Monitoring this helps investors assess the age and remaining utility of the company's capital asset base.